Date published: 2025-9-9

00800 4573 8000

SCBT Portrait Logo
Seach Input

LTBP-2 Inibitori

LTBP-2 inhibitors are a specialized class of compounds designed to target and inhibit the activity of Latent Transforming Growth Factor Beta Binding Protein 2 (LTBP-2). LTBP-2 is a member of the LTBP family of proteins that play a critical role in the regulation of transforming growth factor-beta (TGF-β) signaling, a key pathway involved in cellular growth, differentiation, and extracellular matrix (ECM) formation. Unlike other members of the LTBP family, LTBP-2 does not directly bind to TGF-β but instead interacts with the ECM and other structural components within the cellular environment. Inhibiting LTBP-2 offers researchers a unique tool to study its distinct role in ECM organization, the modulation of cell-matrix interactions, and its broader impact on cell signaling pathways.

The use of LTBP-2 inhibitors in scientific research is particularly valuable for exploring the non-TGF-β related functions of this protein, which are less understood compared to other LTBP family members. By inhibiting LTBP-2, researchers can disrupt its interactions within the ECM, allowing for a closer examination of how these interactions influence tissue architecture, cell adhesion, and mechanical signaling within various cellular contexts. Additionally, LTBP-2 inhibitors help to unravel the complexities of ECM dynamics, shedding light on how alterations in ECM composition and structure can affect cellular behavior and tissue integrity. This class of inhibitors is essential for advancing our understanding of ECM biology, providing insights into the intricate networks that maintain cellular and tissue homeostasis. Through the study of LTBP-2 inhibitors, researchers can gain a deeper appreciation of the multifaceted roles that ECM components play in regulating cell function and the overall maintenance of cellular environments.

VEDI ANCHE...

Nome del prodottoCAS #Codice del prodottoQuantitàPrezzoCITAZIONIValutazione

SB 431542

301836-41-9sc-204265
sc-204265A
sc-204265B
1 mg
10 mg
25 mg
$80.00
$212.00
$408.00
48
(1)

Può influire indirettamente sulla proteina legante il fattore di crescita beta latente (LTBP), agendo sulla via del TGF-&beta.

LY 364947

396129-53-6sc-203122
sc-203122A
5 mg
10 mg
$105.00
$153.00
4
(1)

Un altro inibitore del TGF-β potrebbe anche influenzare indirettamente la Latent Transforming Growth Factor Beta Binding Protein (LTBP).

Marimastat

154039-60-8sc-202223
sc-202223A
sc-202223B
sc-202223C
sc-202223E
5 mg
10 mg
25 mg
50 mg
400 mg
$165.00
$214.00
$396.00
$617.00
$4804.00
19
(1)

Un altro inibitore delle MMP; potrebbe anche influenzare indirettamente la Latent Transforming Growth Factor Beta Binding Protein (LTBP).

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Inibitore di PI3K/Akt/mTOR; potrebbe modulare indirettamente la proteina legante il fattore di crescita beta latente (LTBP).

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Un altro inibitore di PI3K/Akt/mTOR; potrebbe anche influenzare indirettamente la proteina beta legante del fattore di crescita trasformante latente (LTBP).

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Ha come bersaglio mTOR e potrebbe quindi modulare indirettamente la Latent Transforming Growth Factor Beta Binding Protein (LTBP).

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$62.00
$112.00
$214.00
$342.00
74
(2)

Un altro inibitore dell'EGFR; potrebbe anche influenzare indirettamente la proteina legante del fattore di crescita beta latente (LTBP).

Halofuginone

55837-20-2sc-507290
100 mg
$1740.00
(0)

Inibitore di Smad3; potrebbe quindi influenzare indirettamente la proteina legante del fattore di crescita beta trasformato latente (LTBP) attraverso la segnalazione Smad-dipendente.